Literature DB >> 2439923

Renal and iliac vascular effects of dopamine in the anaesthetized rat.

M Schmidt, E Giesen-Crouse, J L Imbs.   

Abstract

The renal and iliac vascular effects of dopamine were compared in pentobarbital anaesthetized rats. Local vascular resistances were calculated from simultaneous measurement of blood pressure, renal and iliac blood flow. Without pretreatment, dopamine increased renal and iliac vascular resistance. After pretreatment with prazosin, dopamine decreased the renal vascular resistance while the iliac vascular resistance was still increased. After a combination of yohimbine and prazosin pretreatment, dopamine lowered both the renal and iliac vascular resistance by 30%. These responses were not modified by the beta-adrenoceptor antagonist, sotalol, or by pretreating the rats with reserpine. The renal but not the iliac vascular response to dopamine was abolished by (+)-butaclamol, a stereoselective dopamine receptor antagonist, and by SCH 23390, the DA1-selective dopamine receptor antagonist. The decrease in iliac vascular resistance was not modified by indomethacin or the non-selective 5-HT receptor antagonist, metitepin. These results show that after blockade of alpha 1 and alpha 2-adrenoceptors, dopamine induces iliac vasodilation by a postsynaptic mechanism independent of an interaction with beta-adrenoceptors, dopamine or serotonin receptors. They also confirm in the rat in vivo the existence of renal vasodilation mediated by DA1 dopamine receptors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2439923     DOI: 10.1007/bf00165551

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  26 in total

1.  EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW.

Authors:  R H MCDONALD; L I GOLDBERG; J L MCNAY; E P TUTTLE
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

2.  Studies on the action and interaction of dopamine and prostaglandin A1 in the renal vasculature.

Authors:  R G Pendleton; P W Woodward
Journal:  Arch Int Pharmacodyn Ther       Date:  1976-06

3.  The depressor and renal vasodilator responses to dopamine in the rat do not depend on prostaglandin biosynthesis.

Authors:  M J Robertson; N M Horn; B J Chapman
Journal:  J Pharm Pharmacol       Date:  1980-11       Impact factor: 3.765

4.  Differential large and small vessel responses to serotonin in the dog hindlimb in vivo: role of the 5HT2 receptor.

Authors:  J L Blackshear; C Orlandi; J D Garnic; N K Hollenberg
Journal:  J Cardiovasc Pharmacol       Date:  1985 Jan-Feb       Impact factor: 3.105

5.  Vascular dopamine receptors in the canine hindlimb.

Authors:  C Bell; E L Conway; W J Lang; R Padanyi
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

6.  Dopamine decreases mesenteric blood flow in the anaesthetised dog through the stimulation of postsynaptic alpha 2-adrenoceptors.

Authors:  N B Shepperson; N Duval; S Z Langer
Journal:  Eur J Pharmacol       Date:  1982-07-30       Impact factor: 4.432

7.  Receptor mechanisms for 5-hydroxytryptamine in rabbit arteries.

Authors:  J L Black; R J French; E J Mylecharane
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

8.  Localization of vasodilator dopamine receptors in the canine hindlimb.

Authors:  C Bell; A Stubbs
Journal:  Br J Pharmacol       Date:  1978-10       Impact factor: 8.739

9.  Consistent unmasking of dopamine-induced dilation of the canine femoral vascular bed.

Authors:  J J Listinsky; J D Kohli; L I Goldberg
Journal:  J Pharmacol Exp Ther       Date:  1980-12       Impact factor: 4.030

10.  A study of dopamine receptors in guinea-pig renal tissue.

Authors:  M Marcou; K A Munday; N Horn; G N Woodruff
Journal:  Arch Int Pharmacodyn Ther       Date:  1982-09
View more
  1 in total

1.  Vascular effects of loop diuretics: an in vivo and in vitro study in the rat.

Authors:  M Barthelmebs; D Stephan; C Fontaine; M Grima; J L Imbs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-02       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.